CPHI Europe

Strategic Insights for 2025
October 31, 2024

Alec McChesney (BD Director, SCORR Marketing) discusses goal setting and alignment between life sciences marketing and business development teams.

CPHI Milan 2024: Highlighting the Benefits of Integrated Services
October 25, 2024

Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated services and the benefits these services can provide to pharma companies.

Evonik Wins Award at CPHI Milan for Plant-based Parenteral Drug Delivery Adjuvant
October 11, 2024

Evonik won the CPHI Excellence in Pharma Award in the “Sustainability” category in recognition of its plant-based squalene, PhytoSquene, used in parenteral drug delivery applications.

CPHI Milan 2024: Pharma Industry Growth and Investment
October 11, 2024

Pharmaceutical Technology Europe spoke with John McQuaid, president and managing director at Almac Pharma Services, at CPHI Milan 2024, held October 8–10, in Milan, Italy, about how the pharmaceutical industry is growing and what might drive investment in the future.

CPHI Milan 2024: What Does the Future Pharma Workforce Look Like?
October 10, 2024

Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies.

CPHI Milan 2024: Pharma Developments in Emerging Markets
October 10, 2024

Rafael Ferrer, interim chief business officer at Acino, talked about his company's recent efforts to reach customers in Africa, the Middle East, and most recently, Latin America.

CPHI Milan 2024: The Usefulness of Fully Connected Continuous Manufacturing
October 10, 2024

Enzene Biosciences CEO Himanshu Gadgil talked about fully connected continuous manufacturing's role in providing equity for biotech companies that may not normally be able to afford such services.

CPHI Milan 2024: New Developments in ADC Technologies
October 10, 2024

Nicolas Camper, senior director—Bioconjugation Chemistry, Abzena, discussed new advancements in ADC technologies, including the role of complex chemistries.

CPHI Milan 2024: Improving Efficiency and Reducing Costs for Oral Solid Dosage Forms
October 09, 2024

Michelle Logan, vice president of the drug product division for Thermo Fisher Scientific, talked about expanding capability to better serve customers in the OSD market.

CPHI Milan 2024: Evolution of Coating Design
October 09, 2024

Pharmaceutical Technology Europe spoke with Ali Rajabi-Siahboomi, vice president and chief innovation officer at Colorcon, about the evolution of coating design and how it has impacted investment, as well as innovations in packaging for oral solid dosage products.